GO Term |
---|
Golgi lumen |
lysosomal lumen |
extracellular region |
extracellular space |
collagen-containing extracellular matrix |
GO Term |
---|
extracellular matrix structural constituent conferring compression resistance |
RNA binding |
glycosaminoglycan binding |
extracellular matrix binding |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
262 |
|
|
Pathway Name | Organism |
---|---|
A tetrasaccharide linker sequence is required for GAG synthesis | Homo sapiens |
CS/DS degradation | Homo sapiens |
Chondroitin sulfate biosynthesis | Homo sapiens |
Defective B3GALT6 causes EDSP2 and SEMDJL1 | Homo sapiens |
Defective B3GAT3 causes JDSSDHD | Homo sapiens |
Defective B4GALT7 causes EDS, progeroid type | Homo sapiens |
Defective CHST14 causes EDS, musculocontractural type | Homo sapiens |
Defective CHST3 causes SEDCJD | Homo sapiens |
Defective CHSY1 causes TPBS | Homo sapiens |
Degradation of the extracellular matrix | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0110287 | autosomal recessive limb-girdle muscular dystrophy type 2S | |
DOID:0110289 | autosomal recessive limb-girdle muscular dystrophy type 2Y | |
DOID:0110292 | autosomal recessive limb-girdle muscular dystrophy type 2O | |
DOID:0110293 | autosomal recessive limb-girdle muscular dystrophy type 2P | |
DOID:0110294 | autosomal recessive limb-girdle muscular dystrophy type 2T | |
DOID:0110295 | autosomal recessive limb-girdle muscular dystrophy type 2U | |
DOID:0110296 | autosomal recessive limb-girdle muscular dystrophy type 2M | |
DOID:0110297 | autosomal recessive limb-girdle muscular dystrophy type 2K | |
DOID:0110298 | autosomal recessive limb-girdle muscular dystrophy type 2N | |
DOID:0110299 | autosomal recessive limb-girdle muscular dystrophy type 2I |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024